Search Within

David Sermer

Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies, Division of (11)
  4. Executive Committee, Center for Hematologic Malignancies (10)
  5. Lymphoma (10)
  6. Biostatistics Service (9)

More Groups

People
  1. Anas Younes (10)
  2. Ahmet Dogan (8)
  3. Alison Moskowitz (8)
  4. Connie Batlevi (8)
  5. Matthew Matasar (8)
  6. Venkatraman Seshan (8)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (3)
  4. 2019 (6)
Publications
  1. Hematological Oncology (4)
  2. Blood (2)
  3. Blood Advances (2)
  4. Blood Cancer Journal (1)
  5. Journal of Clinical Oncology (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Wiley Blackwell (4)
  3. Nature Publishing Group (2)
  4. American Society of Clinical Oncology (1)
  5. Taylor & Francis Group (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma
    Journal Article

    Van Le, H.; Van Naarden Braun, K.; Nowakowski, G. S.; Sermer, D.; Radford, J.; Townsend, W.; Ghesquieres, H.; Menne, T.; Porpaczy, E.; Fox, C. P.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Journal Article

    Bobillo, S.; Joffe, E.; Sermer, D.; Mondello, P.; Ghione, P.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Journal Article

    Sermer, D.; Bobillo, S.; Dogan, A.; Zhang, Y.; Seshan, V.; Lavery, J. A.; Batlevi, C.; Caron, P.; Hamilton, A.; Hamlin, P.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Emerging epigenetic-modulating therapies in lymphoma
    Review

    Sermer, D.; Pasqualucci, L.; Wendel, H. G.; Melnick, A.; Younes, A.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
    Meeting Abstract

    Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical significance and outcomes in patients with diffuse large B‐cell lymphoma (DLBCL) harboring extra copies [EC] and/or translocations [TL] of MYC, BCL2, and BCL6
    Meeting Abstract

    Sermer, D.; Bobillo, S.; Seshan, V.; Dogan, A.; Younes, A.
    Hematological Oncology (2019)

    Fulltext@MSK | Save